Expanding overseas medical-equipment sales and improving quality control
First written in FY2018-Q2. 10 of 24 entries say "Restated". Latest entry: FY2026.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Against this backdrop, to accommodate increased production, we have begun expanding the Medical Equipment Wakamiya Plant and are developing new products for each market.」
In response to the expansion of overseas medical equipment sales, the company describes the start of the Medical Equipment Wakamiya Plant expansion and the development of new products for each market, in addition to increased sales to overseas markets including North America. - 2026-08-13RestatedRevision of earnings forecasts
「Medical equipment increased from the previous consolidated fiscal year because production increases began in the third quarter after the parts shortage was resolved, leading to higher overseas sales, including in North America.」
The increase in overseas medical-equipment sales, including in North America, following higher production after resolution of the parts shortage is reconfirmed. - FY2025RaisedAnnual report
「Meanwhile, the number of dialysis patients worldwide, particularly in China and India, is increasing, while shipments to North America have entered full swing. As a result, overseas sales account for more than 80% of the company's hemodialysis machines.」
The proportion of overseas sales of hemodialysis machines rose from more than 70% to more than 80%, with shipments to North America entering full swing. - FY2025-H1RestatedAnnual report
「Sales in the Mechatronics Systems Business increased from the same period of the previous year, as semiconductor manufacturing systems saw higher sales of LED bonders and inspection equipment to Thailand, while medical equipment sales to overseas markets including North America and Southeast Asia were strong and increased substantially.」
The company reiterates its record of strong growth in overseas medical equipment sales, including sales to North America and Southeast Asia, as part of its overseas market expansion. - FY2024-Q3RestatedAnnual report
「Medical equipment sales increased from the previous year due to strong overseas sales, particularly in Europe, North America and India.」
The company reiterates its record of strong growth in overseas medical equipment sales, including sales to Europe, North America and India, as part of its overseas market expansion. - FY2023RestatedAnnual report
「Overseas, the number of dialysis patients worldwide has increased in recent years, mainly in China and India, and overseas sales account for more than 70% of the company's hemodialysis equipment sales. Against this backdrop, the company has been developing products for the previously untapped US market, conducting market evaluations and establishing a supply system.」
The company reconfirms that overseas sales account for more than 70% of hemodialysis machines, and that it is developing products for the U.S. market, evaluating the market and establishing a supply system. - FY2023-Q3Continued recovery in overseas salesAnnual report
「Medical equipment sales increased from the same period of the previous year as overseas markets including India, Europe and South Korea recovered from the substantial decline caused by the impact of COVID-19.」
The company states that sales of medical equipment are continuing to recover in overseas markets including India, Europe and South Korea. - FY2023-Q2Expansion of regions seeing a recovery in overseas medical equipment salesAnnual report
「Medical equipment sales increased from the same period of the previous year as overseas markets including India, Europe, South Korea and Taiwan recovered from the substantial decline caused by the impact of COVID-19.」
The recovery in overseas medical equipment sales now includes South Korea and Taiwan, in addition to the previously cited markets such as India, Southeast Asia and Europe. - FY2023-Q1Recovery in overseas medical equipment salesAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined significantly due to the economic slowdown caused by the country’s zero-COVID policy, but overseas medical equipment sales, including to India, Southeast Asia and Europe, recovered rapidly from the sharp decline caused by COVID-19 and increased significantly.」
Sales of medical equipment to overseas markets, which had previously declined, including India, Southeast Asia and Europe, are recovering rapidly and increasing significantly. - FY2022RestatedAnnual report
「Overseas, the number of dialysis patients worldwide has increased in recent years, mainly in China and India, and overseas sales account for more than 70% of the company's hemodialysis equipment sales. Against this backdrop, the company has been developing products for the previously untapped US market, conducting market evaluations and establishing a supply system.」
The report reconfirms that overseas sales account for more than 70% of hemodialysis equipment sales and that the company is developing products for the US market and establishing a supply system. - FY2022-Q2Recovery in medical equipment demandAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales increased against the backdrop of expanding capital investment demand in China aimed at improving semiconductor self-sufficiency, as in the previous fiscal year. Medical equipment sales also recovered slightly from the sharp decline in the previous fiscal year, despite continued weakness in demand for dialysis equipment due to the impact of COVID-19.」
Although the decline in demand for hemodialysis equipment due to the impact of COVID-19 continued, medical equipment demand has recovered somewhat from the substantial decline in the previous fiscal year. - FY2021RestatedAnnual report
「Overseas, the number of dialysis patients worldwide has increased in recent years, mainly in China and India, and overseas sales account for more than 70% of the company's hemodialysis equipment sales. Against this backdrop, the company has been developing products for the previously untapped US market, conducting market evaluations and establishing a supply system.」
The report reconfirms that overseas sales account for more than 70% of hemodialysis equipment sales and that the company is developing products for the US market and establishing a supply system. - FY2021-Q3Continued weakness in demand for hemodialysis equipment in Europe and IndiaAnnual report
「Medical equipment sales declined as demand for hemodialysis equipment, particularly in Europe and India, continued to fall due to the spread of COVID-19, although」
For medical equipment, the decline in demand for hemodialysis equipment in Europe and India due to the spread of COVID-19 has continued. - FY2021-Q2Continued decline in demand for hemodialysis equipment in Europe and IndiaAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing equipment sales increased significantly as demand for capital investment expanded, particularly in China, driven by efforts to increase semiconductor self-sufficiency. However, medical equipment sales declined because demand for dialysis equipment continued to fall, particularly in Europe and India, due to the spread of COVID-19.」
For medical equipment, the report has shifted from the previous quarter's references to declining sales in Japan and China to stating that demand for hemodialysis equipment, particularly in Europe and India, continued to decline during the quarter. - FY2021-Q1Continued decline in demand for hemodialysis equipmentAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing equipment sales increased as market conditions in Japan and overseas moved toward recovery, particularly with higher sales to China, but medical equipment sales declined because demand for dialysis equipment continued to fall, especially under the impact of the spread of COVID-19.」
For medical equipment, the focus has shifted from the previously reported strong overseas sales to the continued decline in demand for hemodialysis equipment due to the spread of COVID-19. - FY2020AdvancedAnnual report
「The company developed products with the previously untapped US market in mind, obtained approval from the US Food and Drug Administration (FDA), expanded its hemodialysis equipment production plant, and established a supply system for the US market.」
The report describes specific progress in expanding overseas medical equipment sales, including obtaining FDA approval, expanding the production plant and establishing a supply system for the US market. - FY2020-Q3Continued decline in domestic and China medical equipment salesAnnual report
「Medical equipment sales declined from the same period of the previous year, particularly because sales to Japan and China decreased.」
As in the previous report, the decline in domestic and China medical equipment sales is mentioned. It does not state that the policy of expanding overseas markets was withdrawn or changed. - FY2020-Q2Decline in domestic and China medical equipment salesAnnual report
「Sales in the Mechatronics Systems Business declined from the same period of the previous year, as semiconductor manufacturing equipment sales fell due to the impact of US-China trade friction and medical equipment sales to Japan and China decreased.」
For medical equipment, the report states that sales to Japan and China, previously described as strong, declined during the quarter. It does not state that the policy of expanding overseas markets was withdrawn or changed. - FY2019-Q3RestatedAnnual report
「Medical equipment sales to Japan, China and Europe were strong and increased because」
The report continues to document strong and increased medical equipment sales to Japan, China and Europe. - FY2019-Q2RestatedAnnual report
「Medical equipment sales to Japan, China and Europe were strong and increased because」
The report continues to document strong and increased medical equipment sales to Japan, China and Europe. - FY2019-Q1RestatedAnnual report
「Medical equipment sales to Japan, China and Europe were strong and increased, although」
The report states that medical equipment sales to Japan, China and Europe were strong and increased, continuing to document results indicating an expansion of sales regions, including overseas markets. - FY2018Expansion of sales regionsAnnual report
「Medical equipment sales to India, China and Europe and semiconductor manufacturing equipment sales to China were strong and increased, respectively, because」
For medical equipment, the report mentions strong sales to India, China and Europe in addition to its previous references to Europe, Southeast Asia and other markets. - FY2018-Q3RestatedAnnual report
「In particular, medical equipment costs increased because the company adopted strategic pricing to expand sales in overseas markets and incurred higher costs to improve quality control,」
The report continues to mention strategic pricing to expand medical equipment sales in overseas markets and spending to improve quality control. - FY2018-Q2First statedAnnual report
「In particular, medical equipment costs increased because the company adopted strategic pricing to expand sales in overseas markets and incurred higher costs to improve quality control」
For medical equipment, the report specifically mentions for the first time the use of strategic pricing to expand sales in overseas markets and spending to improve quality control.